on 02 Jun 2020
Last Applicant/ Owned by
GSK Medicines Research Centre
Stevenage
SG12NY
Serial Number
88728724 filed on 16th Dec 2019
Registration Number
6069531 registered on 02th Jun 2020
Correspondent Address
Elizabeth K. Rucki
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmon Read More
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
No 88728724
No Service/Collective Mark
No 82813995
Yes
No
Yes
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
11th Aug 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
11th Aug 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
11th Aug 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
11th Aug 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
11th Aug 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
08th Nov 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
08th Nov 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
08th Nov 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
08th Nov 2022 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
08th Nov 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |